Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study.
We describe baseline characteristics, time to treatment initiation and interim patient outcomes at a decentralized, outpatient treatment site for rifampicin-resistant TB (RR-TB).Prospective observational cohort study of RR-TB patients from March 2013 until December 2014. Study subjects were followed...
Main Authors: | Rebecca Berhanu, Kathryn Schnippel, Erika Mohr, Kamban Hirasen, Denise Evans, Sydney Rosen, Ian Sanne |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5094796?pdf=render |
Similar Items
-
Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa.
by: Craig van Rensburg, et al.
Published: (2019-01-01) -
High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.
by: Kamban Hirasen, et al.
Published: (2018-01-01) -
Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
by: Denise Evans, et al.
Published: (2018-12-01) -
Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.
by: Denise Evans, et al.
Published: (2017-01-01) -
Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa
by: Denise Evans, et al.
Published: (2018-04-01)